Paul Andrew Moore

Insider Reports History

Location
Vancouver, British Columbia, Canada
Signature
/s/ Daniel Dex, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Paul Andrew Moore:

Form 4 holding Chief Scientific Officer

Zymeworks Inc.

Security class
Common Stock
Shares / value
48,497
Estimated value
$1,099,596
Report date
12 Jan 2026
Price
$22.67
Ownership
Direct
Form 4 holding Chief Scientific Officer

Zymeworks Inc.

Security class
Restricted Stock Unit
Shares / value
47,000
Estimated value
$790,977
Report date
12 Jan 2026
Price
$14.92
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Chief Scientific Officer

Zymeworks Inc.

Security class
Stock Option (Right to Buy)
Shares / value
200,000
Estimated value
Report date
18 Jul 2022
Price
Ownership
Direct
Underlying class
Common Shares
Underlying amount
Form 4 holding Chief Scientific Officer

Zymeworks Inc.

Security class
Stock Option (Right to Buy)
Shares / value
70,000
Estimated value
Report date
12 Jan 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Chief Scientific Officer

Zymeworks Inc.

Security class
Performance Stock Unit
Shares / value
66,000
Estimated value
Report date
12 Jan 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Paul Andrew Moore

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .